Sperling Prostate Center

Reference Publications

  1. AdMeTech Foundation. Prostate cancer crisis: key statistics. http://www.admetech.org/PCC/index.php . (2008).
  2. Aetna, Inc. Clinical policy bulletin: magnetic resonance spectroscopy (MRS). http://www.aetna.com/cpb/medical/data/200_299/0202.html .
  3. Ahmed HU et al. Will focal therapy become a standard of care for men with localized prostate can. Nat Clin Pract Oncol . 4. 632-42. (2007).
  4. Ahmed HU, Kirkham A et al. Is it time to consider a role for MRI before prostate biopsy?. Nat Rev Clin Onc . 6. 197-206. (2009).
  5. Anastasiadis AG et al.. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.. Eur Urol . 50. 738-48. (2005).
  6. Atalar E & Menard C. MR-guided interventions for prostate cancer. Magn Reson. Imaging Clin N Am . 13. 491-504. (2005).
  7. Beyersdorff D et al. Patients with a history of elevated prostate specific antigen levels and negativ. Radiology . 224. 701-706. (2002).
  8. Buyyounouski MK et al. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by. Int J Radiat Oncol Biol Phys . 58. 743-49. (2004).
  9. Chen ME, Johnston DA, Tang K et al. Detailed mapping of prostate carcinoma foci: Biopsy strategy implications. Cancer . 89. 1800-09. (2000).
  10. Cheng ME, Johnston DA, Tang K et al. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA ?10, and clinically localized prostate cancer. J Radiol Oncol Biol Phys . 55. 64-70. (2003).
  11. Coakley FV et al. Prostate cancer tumor volume: Measurement with endorectal MR and MR spectroscopi. Radiology . 223. 91-97. (2002).
  12. Coakley, FV, The HS et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostat. Radiology . 233. 441-48. (2004).
  13. Cook, Daniel. Is robotic prostatectomy overhyped?. http://www.outpatientsurgery.net/news/2012/01/9-Is-Robotic-Prostatectomy-Overhyped . 1. 10. (2012).
  14. Cooperberg M et al. Outcomes for radical prostatectomy: is it the singer, the song, or both?. Journal of Clinical Oncology. http://jco.ascopubs.org/content/early/2012/01/03/JCO.2011.38.9593 . 1. 3. (2012).
  15. Cooperberg MR et al. The changing face of prostate cancer. J Clin Onc . 23. 8146-8151. (2005).
  16. Desouza NM, Reinsberg SA et al. Magnetic resonance imaging in prostate cancer: value of apparent diffusion coeff. Br J Radiol . 80. 90-95. Feb. (2007).
  17. DiMaio SP et al. A system for MRI-guided prostate interventions. International Conference on Biom. BioRob . Feb. (2006).
  18. Djavan B et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3, and 4: w. J Urol . 166. 1979-83. (2001).
  19. Emanuel, Ezekiel J. and Pearson, Steven D.. It costs more, but it is worth more?.
    http://opinionator.blogs.nytimes.com/2012/01/02/it-costs-more-but-is-it-worth-more/?scp=2&sq=ezekiel%20emanuel&st=cse . 1. 2. (2012).
  20. Engelbrecht MR et al. Discrimination of prostate cancer from normal peripheral zone and central gland . Radiology . 229. 248-254 . (2003).
  21. Futterer JJ et al. Staging prostate cancer with dynamic contrast enhanced endorectal MR imaging pri. Radiology . 237. 541-49. (2005).
  22. Futterer JJ, Scheenen TW et al. Initial experience of 3 tesla endorectal coil magnetic resonance imaging and 1-s. Invest Radiol . 39. 671-80. (2004).
  23. Grossfeld G & Carroll P. Prostate cancer early detection: a clinical perspective. Epidemiologic Rev . 23. 173-180. (2001).
  24. Harvard Medical School. 2100 Annual Report on Prostate Diseases. Boston, MA . (2011).
  25. Heerschap A et al. In vivo proton MR spectroscopy reveals altered metabolite content in malignant p. Anticancer Res . 17. 1455-1460. (1997).
  26. Hoskins PJ et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohist. Intl J Rad Biol . 68. 1065-71. (2007).
  27. Hricak, H. MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prost. Br J Radiol . 78. S103-11. (2005).
  28. Hricak, H et al. The role of preoperative endorectal magnetic resonance imaging in the decision r. Cancer . 100. 2655-63. (2004).
  29. Huisman HJ, Engelbrecht MR, Barentsz JO. Accurate estimation of pharmacokinetic contrast-enhanced dynamic MRI parameters . J Magn Reson Imaging . 13. 607-614. (2001).
  30. Ikonen S et al. Magnetic resonance imaging of prostatic cancer: does detection vary between high. Prostate . 43. 43-48. (2000).
  31. Kirkham AP, Emberton M & Allen C. How good is MRI at detecting and characterizing cancer within the prostate?. Eur Urol . 50. 1163-74. (2006).
  32. Kumar V et al. Correlation between metabolite ratios and ADC values of prostate in men with inc. Magn Reson Imaging . 24. 541-48. (2006).
  33. Kumar V et al. Potential of 3D 1H MRSI localization of prostate cancer to direct TRUS guided bi. Proc Intl Soc Mag Reson Med . 14. 1788. (2006).
  34. Kumar V et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious. NMR Biomed . 20. 11-20. (2007).
  35. Stamey TA, Caldwell M et al. The prostate specific antigen era in the United States is over for prostate cancer:. J Urol 172 . 1297-1301. Oct. 04.
  36. Ukimura O, Gill I. Key to successful focal therapy: location, location, location. Eur Urol . 62. 64-67. (2012).
WordPress Image Lightbox